Match Document Document Title
DE102006019480A1 Use of gene expression profiles to detect any postoperative tissue incompatibility reactions after liver transplantation  
Gene expression profiles obtained from a patient sample in vitro are used to detect any postoperative tissue incompatibility reactions after liver transplantation. An independent claim is also...
DE10014639B4 cDNSen with a coding of enzymes for fructan synthesis with a low-temperature expression as well as methods for their isolation  
process to isolate a cDNA that encodes an enzyme for fructan synthesis, which is active at a temperature of about 4 ° C, characterized by the following steps: - Cold-conditioning a winter wheat...
DE102007018551A1 Preparing gemcitabine comprises reducing a dihydro-furan-2-one compound to give a furan compound, activating the hydroxyl group and reacting with a protected cytosine to give a protected nucleoside and terminal protection of the nucleoside  
Preparation of gemcitabine comprises reducing a dihydro-furan-2-one compound (16A) to give a furan compound (19), activating the hydroxyl group by converting into a sulfonate (mesylate), reacting...
DE102006017492A1 Drug fixation on polymer surfaces  
Of the The present invention relates to compounds according to the general Formula 1, where R1. R2, R3, R4, R5, R6. R7, R8th, R9 and R10 independently selected are selected from the group...
DE10045123B4 The C. albicans TEC1 GEN (CaTEC1) and the encoded protein Tec1p  
Nucleic acid molecule which for cloning a gene encoding a transcription factor is suitable and / or a protein having the biological activity of a transcription factor coded and as a means for...
DE10006590B4 Using Functionalized membranes or matrices for purifying nucleic acids and corresponding methods  
use a functionalized porous Membrane for purifying nucleic acids, the binding properties for nucleic acids over the Conditions in a surrounding medium can be adjusted, characterized in that the...
DE19811540B4 Apicularen A, processes for its preparation and cytostatic agent with apicularen A  
apicularen A of formula
DE10228785B4 Detection of toxic algae  
oligonucleotide characterized in that one of the sequences SEQ ID No.1 to 19 exhibits.
DE202007003784U1 Apparatus for the purification of biomolecules  
device for the purification of biomolecules having by adsorptive separation in a a flat adsorbent (6) Chromatography module (2), the housing (3) at least one inlet (4) and at least one outlet (5)...
DE102006011077A1 A method for degradation of cellulose with nucleophiles  
The This invention describes a method for degradation of cellulose, by dissolving cellulose in an ionic liquid and with a nucleophile treated.
DE102006011076A1 Degradation of poly-, oligo- or di-saccharide or derivative e.g. partial degradation of cellulose for fiber or film production or complete degradation to glucose involves heating solution in ionic liquid e.g. quaternary ammonium compound  
Process for degradation of poly-, oligo- or di-saccharides or their derivatives comprises dissolving the material in ionic liquid(s) and treated at elevated temperature, optionally with addition...
DE102006011075A1 Process for the degradation of cellulose in solution  
The This invention describes a method for degradation of cellulose, by dissolving the cellulose in an ionic liquid and with an acid, optionally the addition of water, treated.
DE102004028241B4 New fluoroglycoside derivatives of pyrazoles, pharmaceutical compositions containing them and the preparation of these drugs  
compounds of formula I, which mean R1 and R2 independently of one another, F or H, where one of the radicals R1 or R2 must be F; A O, NH, CH2, S or a bond; R3 Hydrogen, F, Cl, Br, I, OH, CF3, NO2,...
DE10262018B4 Compositions, foodstuffs, foods, and beverages, confectionery, pet food, dietary special diet, child nutrition, sweeteners and pharmaceutical compositions containing condensed Palatinose  
The Invention relates to compositions, food, food and beverages, Confectionery, Animal feed, dietary Special diet, Child nutrition, sweeteners and to pharmaceutical compositions containing a new...
DE4411176B4 Developer for PS plates and supplemental fluids for developer  
developer for presensitized photosensitive plates for making lithographic printing plates, containing an alkali metal silicate having a molar ratio SiO2/ M2O (wherein M represents an alkali metal...
DE102006008701A1 Procedure for transferring biomolecules into a cell, comprises preparing a complex from biomolecule and polymer, and transferring the biomolecule into a cell by contacting the cell with the complex  
Procedure for transferring biomolecule into a cell, comprises preparing a complex from the biomolecule, preferably nucleic acid, and a polymer, which is obtained through reacting an amine-monomer...
DE19720839B4 Modular technology for the production of long, exact DNA constructs in vitro, in particular for the preparation of constructs for the production of artificial chromosomes (MAC, mammalian artificial chromosome) of two stable cloned DNA components and the prototype vector ditelomerische PTAT  
process for in vitro production of about 50 Kb long DNA constructs by directed, site-specific Recombination, characterized in that it comprises the steps of: a) Independent cloning of two DNA...
DE20122767U1 Massive parallel method for decoding DNA and RNA  
On Nucleotide analogue which comprises: a) a base selected from the group consisting of adenine or an analogue of adenine, Cytosine or an analogue of cytosine, guanine or an analogue of Guanine,...
DE102005033903B4 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them  
perfluoroalkyl Metal complexes having N-alkyl group of the general formula I in which R either one about 1-OH-bonded mono- or oligosaccharide represents the optional is peralkylated, in this case...
DE10138935B4 Synthetic compounds from non-mucin or its conjugated with a carrier compounds, monoclonal antibodies produced using them, this comprehensive anti-tumor agent and immune stimulants means to human immunodeficiency virus  
connection of the general formula (1) wherein A represents OH or sialic acid, and B OH or galactose is; T for H or amino group; M is H or OH; X is an oxygen atom, -NH- Or S (O) z (where z is 0, 1...
DE202007003503U1 Galatenoside and their use as antidepressants  
Polygalatenosid the following structure: comprising racemic mixtures of optically active compounds or optically pure R and S stereoisomers, in which R, R 'and R' 'independently H or R1 constitute,...
DE19903056B4 HPV Assay  
process to amplify existing in biological samples HPV DNA, characterized in that a) a sample optionally subjecting a protease digestion, b) the nucleic acids separating of protease and other...
DE102006001759A1 Synthesis of metal nanoparticles and nanocrystals, useful particularly for silver disinfection of e.g. medical instruments, uses a silicatein protein, also new silicateins and nucleic acid encoding them  
Method for synthesizing nanoparticles and nanocrystals (X) from gold, silver and other transition metals that uses a protein (I), or its metal complex, where (I) comprises an animal, bacterial,...
DE19981703B4 A process for increasing the purity of the racemic form of metallocene  
process to increase the purity of the racemic form of metallocene complexes comprising the steps of (a) adding a compound of LiOH, NaOH and / or KOH or an amine and - water a mixture comprising a...
DE10241208B4 Presbyopiekorrigierende contact lens and methods of manufacture for such a contact lens  
Presbyopiekorrigierende Contact lens (1, 20, 30, 60) with at least one near-vision zone (8, 21, 32, 66) with high refractive power and at least one far vision zone (9, 22, 33, 65) with a lower...
DE102005063244A1 New 2-nitroimidazole derivatives, useful for detecting hypoxic tissue especially associated with tumors, diabetes, stroke and/or circulatory diseases, have substituent that mediates transport into biological cells  
New 2-nitroimidazole derivatives (I) have a substituent (or vehicle) that mediates transport into biological cells via cellular transport systems. Independent claims are also included for the...
DE102005059242A1 Molecular markers for tumor diagnosis and therapy  
The This invention relates to the diagnosis, prognosis, monitoring and therapy of neoplastic diseases such as tumor diseases, in particular Cancers of the endometrium and their metastases.
DE102005058542A1 Erythruloseester as UV filters  
The Invention relates to compounds according to formula I, wherein X, Y and Z are O, NH or N-alkyl, Sp, Sp ', Sp' 'can be identical or different and are -H, - (CH2)n-, - (CH2)n-C (= O) - (CH2)O-...
DE102005058431A1 Nucleic acid useful as a target for detecting species of yeasts and/or filamentous fungi comprises an elongation factor 3 gene or a fragment thereof  
Nucleic acid (I) comprising the elongation factor 3 gene of yeasts and filamentous fungi or a fragment thereof is new. New nucleic acid (I) comprises a nucleic acid (Ia) with a sequence selected...
DE102005057334A1 A method for isolating nucleic acids from any starting materials  
object the invention is a universal and highly simplified procedure for isolating nucleic acids of nucleic acids containing diverse feedstocks using a combination from buffers with chaotropic...
DE10051628B4 Single stranded oligonucleotide and its use  
Single stranded oligonucleotide with a Konjungat, wherein the oligonucleotide four specific nucleotides includes, characterized in that the four specific nucleotides only the carry base cytosine...
DE19735868B4 Verfahren zur Herstellung gemischter Glucosaminsalze in einer therapeutisch wirksamen kristallinen Form  
Verfahren zur Herstellung einer therapeutisch wirksamen kristallinen Form von Glucosaminsulfat, die bei Umgebungstemperatur und -feuchtigkeit stabil ist und der empirischen Formel: entspricht, in...
DE10333509B4 Directed against VEGF recognition molecules and the use of these  
Recognition molecule directed, against the gene of the Vascular Endothelial Growth Factor, characterized in that that the recognition molecule, which is a nucleic acid construct selected of an...
DE19900681B4 Using Anionaustauschermembranen for the removal of endotoxins from solutions containing nucleic acid  
use microporous weak basic Anionaustauschermembranen type Sartobind® D in a Anion exchange chromatography for the removal of endotoxins from Nucleic acid-containing Solutions.
DE102005046361A1 Detection and differentiation of Salmonella serovars, especially parathyphi B and Java, useful for analysis of e.g. food, clinical and water samples, based on amplification of gene STM3356  
Method for detecting and/or differentiating Salmonella serovars (A). Method for detecting and/or differentiating Salmonella serovars (A) comprises (i) amplifying a region of the STM3356 gene,...
DE102005047736A1 Method to isolate nucleic acid comprises protectively solubilizing biological sample in buffer, adding alcoholic component/non ionic detergent, binding nucleic acid to solid phase, washing with buffer and eluting with salt buffer/water  
Method for isolation of nucleic acid from nucleic acid material comprises protectively solubilizing biological sample in a previously known buffer solution, which is provided with no chaotropic or...
DE102005033902B3 Perfluoroalkyl-containing complexes, processes for their preparation, and their use and pharmaceutical compositions containing them  
The Invention relates to the marked in the patent claims, namely perfluoroalkyl Metal complexes with nitrogen-containing groups of the general formula I, to processes for their preparation and...
DE102005046490A1 New nucleic acid molecule comprising promoter, a transcriptable nucleic acid sequence, a first and second nucleic acid sequence for producing modified RNA with transcriptional stability and translational efficiency  
Nucleic acid molecule comprising (in 5'-3' transcription direction) (a) a promoter; (b) a transcriptable nucleic acid sequence or a nucleic acid sequence for inserting in to a transcriptable...
DE10006591B4 A method for purification of nucleic acids  
process for the purification of nucleic acids from nukleinsäurehaltigem Starting material having a porous Membrane made of plastic, in which - The optionally pre-purified starting material mixed...
DE102005042828A1 Selected CGPR antagonists, process for their preparation and their use as medicaments  
object the present invention relates to the CGRP-antagonists of general Formulas I, in which R1, R2 and R3 are as defined in claim 1, their Tautomers, the isomers, the diastereomers, deren...
DE19958198B4 The IGF-1 receptor interacting proteins (IIPs)  
Nucleic acid, thereby in that they for a binding to the IGF-I receptor protein encoded selected from the group: (A) in SEQ ID NO: 5 nucleic acid sequence shown, (B) Nucleic acid sequences, which...
DE112004002170T5 Improved methods and compositions for RNA interference  
process to weaken the expression of a target nucleotide sequence in a eukaryotic Cell, said method comprising: introducing double-stranded RNA (DsRNA) into the eukaryotic cell to the expression of...
DE102005040259A1 A process for recovering nucleic acids from blood  
The This invention relates to an improved process for isolating of nucleic acids in particular from genomic deoxyribonucleic acid (DNA) from blood.
DE10253351B4 Novel Pufferfomulierungen for isolation, purification and recovery of long- and short-chain nucleic acids  
process for isolating nucleic acids from a solution characterized by binding to a solid phase, characterized in that one containing the nucleic acid solution with additions is adjusted so that...
DE10242062B4 Hydrogenated condensed palatinose, processes for their preparation and their use  
process for the production of hydrogenated condensed Palatinose comprising containing the catalytic hydrogenation of a condensed Palatinose aqueous solution at an elevated Temperature of 40 ° C to...
DE102005035461A1 Stable NAD / NADH derivatives  
The Invention relates to stable nicotinamide adenine dinucleotide (NAD / NADH) - or nicotinamide adenine dinucleotide phosphate (NADP / NADPH) derivatives, Enzyme complexes of these derivatives...
DE19930177B4 Intermolecularly associating compounds and their use  
connection of the general formula (I) X (B)m (I)in which X an m-valent moiety and for CH4-m; NH3-m; N+H4-m; > P- (when m = 3); > P+<(When m = 4); > B- (when m = 3); a linear atomic group C2H6-m; >...
DE102005036542A1 CTL prodrug  
The This invention relates to a polypeptide having preferably antitumoral and / or immunomodulatory Zytokineigenschaften through which Processing in vivo is activated, comprising a C-terminal...
DE102006035020A1 Test element for determining analytes, comprises stabilized coenzyme and coenzyme-dependent enzyme, used especially for determination of glucose  
A test element (A) for determination of an analyte comprises: (i) a coenzyme-dependent enzyme (E) or a substrate for E; and (ii) as a coenzyme, a stabilized NAD derivative (I), or its salts or...
DE102004010219B4 HKI10311129, new antibiotic, to processes for its preparation and medicaments containing HKI10311129  
connection (HKI10311129) with molecular weight 1113 and the empirical formula C56H75NO22. wherein the structural formula applies: